Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Postoperative Complications and Mobilization Following Major Abdominal Surgery With Versus Without Fitness Tracker-based Feedback (EXPELLIARMUS): A Student-led Multicenter Randomized Controlled Clinical Trial of the CHIR-Net SIGMA Study Group.
Mihaljevic AL; CHIR-Net SIGMA Study Group. Mihaljevic AL, et al. Ann Surg. 2024 Aug 1;280(2):202-211. doi: 10.1097/SLA.0000000000006232. Epub 2024 Feb 9. Ann Surg. 2024. PMID: 38984800 Free PMC article. Clinical Trial.
Facilitating human papillomavirus vaccination pathways by extending vaccination competencies to community pharmacists: A cross-sectional survey on the acceptability and expectations among healthcare professionals and parents.
Julia B, Farge G, Mourlat B, Mamane C, Bensimon L, Hommel C, Conan G. Julia B, et al. Explor Res Clin Soc Pharm. 2023 Mar 30;10:100255. doi: 10.1016/j.rcsop.2023.100255. eCollection 2023 Jun. Explor Res Clin Soc Pharm. 2023. PMID: 37396108 Free PMC article.
Infections in LVAD patients.
Julia BV, Yochiro N, Matthias L. Julia BV, et al. J Card Surg. 2022 Aug;37(8):2307-2308. doi: 10.1111/jocs.16591. Epub 2022 May 19. J Card Surg. 2022. PMID: 35589559
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group. Rubin DT, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798036 Clinical Trial.
47 results